The association between sporadic Alzheimer's disease and the human ABCA1 and APOE gene polymorphisms in Iranian population

Iranian Red Crescent Medical Journal

Volumn 13, Issue 4, 2011, Pages 256-262

  Khorshid, H R Khorram ^a   Gozalpour, E ^a   Kamali, K ^b   Ohadi, M ^a   Karimloo, M ^a   Shahhosseiny, M H ^c  

^a UNIVERSITY OF SOCIAL WELFARE AND REHABILITATION SCIENCES   (Iran)

^b AVICENNA RESEARCH INSTITUTE   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Alzheimer's disease; Apolipoprotein E; ATP binding cassette transporter A1; Genetic association; Iran; Polymorphism

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE;

EID: 79954563469     PISSN: 20741804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. St George-Hyslop PH, Petit A. Molecular biology and genetics of Alzheimer's disease. C R Biol 2005;328:119-30. [15770998] [doi:10.1016/j.crvi.2004.10.013]
2. Avella AMB, Oostra BA, Heutink P. Chasing genes in Alzheimer's and Parkinson's disease. Hum Genet 2004;114:413-38. [14999561] [doi:10.1007/s00439-004-1097-7]
3. Hirsch-Reinshagen V, Zhou S, Burgess BL, Bernier L, McIsaac SA, Chan JY, Tansley JH, Cohn JS, Hayden MR, Wellington CL. Deficiency of ABCA1 impairs Apolipoprotein E metabolism in brain. J Biol Chem 2004;279:41197-207. [15269218] [doi:10.1074/jbc.M407962200]
4. Hooijmans CR, Kiliaan AJ. Fatty acids, lipid metabolism and Alzheimer pathology. Eur J Pharmacol 2008;585:176-96. [18378224] [doi:10.1016/j.ejphar.2007.11.081]
5. Wahrle SE, Jiang H, Parsadanian M, Legleiter J, Han X, Fryer JD, Kowalewski T, Holtzman DM. ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE. J Biol Chem 2004;279:40987-93. [15269217] [doi:10.1074/jbc.M407963200]
6. Puglilli L, Tanzi RE, Kovacs DM. Alzheimer's disease: Cholesterol connection. Nat Neurosci 2003;6:345-51. [12658281] [doi:10.1038/nn0403-345]
7. Shibata N, Kawarai T, Lee JH, Lee H-S, Shibata E, Sato C, Liang Y, Duara R, Mayeux RP, St George-Hyslop PH, Rogaeva E. Association studies of cholesterol metabolism genes (CH25H, ABCA1 and CH24H) in Alzheimer's disease. Neurosci Lett 2006;391:142-6. [16157450] [doi:10.1016/j.neulet.2005.08.048]
8. Sundar PD, Feingold E, Minster RL, DeKosky ST, Kamboh MI. Genderspecific association of ATP-binding cassette transporter 1 (ABCA1) polymorphisms with the risk of lateonset Alzheimer's disease. Neurobiol Aging 2007;28:856-62. [16725228] [doi:10.1016/j.neurobiolaging.2006.04.005]
9. Fassbender K, Simons M, Bergmann C, Stroick M, Lutjohann D, Keller P, Runz H, Kuhl S, Bertsch T, von Bergmann K, Hennerici M, Beyreuther K, Hartmann T. Simvastatin strongly reduces levels of Alzheimer's disease betaamyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc Natl Acad Sci U S A 2001;51;98:5856-61. [11296263] [doi:10.1073/pnas.081620098]
10. Kojro E, Gimpl G, Lammich S, Marz W, Fahrenholz F. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha - secretase ADAM 10. Proc Natl Acad Sci U S A 2001;98:5815-20. [11309494] [doi:10.1073/pnas.081612998]
11. Richard F, Amouyel P. Genetic susceptibility factors for Alzheimer's disease. Eur J Pharmacol 2001;412:1-12. [11166730] [doi:10.1016/S0014-2999(00)00903-1]
12. Tanzi RE, Bertram L. New Frontiers in Alzheimer's disease Genetics. Neuron 2001;32:181-4. [11683989] [doi:10.1016/S0896-6273(01)00476-7]
13. Wang F, Jia J. Polymorphisms of cholesterol metabolism genes CYP46 and ABCA1 and the risk of sporadic Alzheimer's disease in Chinese. Brain Res 2007;1147:34-8. [17335784] [doi:10.1016/j.brainres.2007.02.005]
14. Wolozin B, Kellman W, Ruosseau P, Celesia GG, Siegel G. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3- methyglutaryl coenzyme A reductase inhibitors. Arch Neurol 2000;57:1439-43. [11030795] [doi:10.1001/archneur.57.10.1439]
15. Wollmer MA, Streffer JR, Lütjohann D, Tsolaki M, Iakovidou V, Hegi T, Pasch T, Jung HH, Bergmann K, Nitsch RM, Hock C, Papassotiropoulos A. ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease. Neurobiol Aging 2003;24;421-6. [12600718] [doi:10.1016/S0197-4580(02)00094-5]
16. Selkoe DJ. Alzheimer's Disease: Genes, Proteins, and Therapy. Physiol Rev 2001;81:741-66. [11274343]
17. Wavrant-De Vrièze F, Compton D, Womick M, Arepalli S, Adighibe O, Li L, Pérez-Tur J, Hardy J. ABCA1 polymorphisms and Alzheimer's disease. Neurosci Lett 2007;416:180-3. [17324514] [doi:10.1016/j.neulet.2007.02.010]
18. Blacker D, Bertram L, Saunders AJ, Moscarillo TJ, Albert MS, Wiener H, Perry RT, Collins JS, Harrell LE, Go RC, Mahoney A, Beaty T, Fallin MD, Avramopoulos D, Chase GA, Folstein MF, McInnis MG, Bassett SS, Doheny KJ, Pugh EW, Tanzi RE; NIMH Genetics Initiative Alzheimer's Disease Study Group. Results of a high-resolution genome screen of437 Alzheimer's Disease families. Hum Mol Genet 2003;12:23-32. [12490529] [doi:10.1093/hmg/ddg007]
19. Liang Y, Lin S, Beyer TP, Zhang Y, Wu X, Bales KR, DeMattos RB, May PC, Li SD, Jiang XC, Eacho PI, Cao G, Paul SM. A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes. J Neurochem 2004;88:623-34. [14720212] [doi:10.1111/j.1471-4159.2004.02183.x]
20. Katzov H, Chalmers K, Palmgren J, Andreasen N, Johansson B, Cairns NJ, Gatz M, Wilcock GK, Love S, Pedersen NL, Brookes AJ, Blennow K, Kehoe PG, Prince JA. Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism. Hum Mutat 2004;23:358-67. [15024730] [doi:10.1002/humu.20012]
21. Li Y, Tacey K, Doil L, van Luchene R, Garcia V, Rowland C, Schrodi S, Leong D, Lau K, Catanese J, Sninsky J, Nowotny P, Holmans P, Hardy J, Powell J, Lovestone S, Thal L, Owen M, Williams J, Goate A, Grupe A. Association of ABCA1 with late-onset Alzheimer's disease is not observed in a case-control study. Neurosci Lett 2004;366:268-71. [1528843] [doi:10.1016/j.neulet.2004.05.047]
22. Raygani AV, Zahrai M, Raygani AV, Doosti M, Javadi E, Rezaei M, Pourmotabbed T. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran. Neurosci Lett 2005;375:1-6. [15664112] [doi:10.1016/j.neulet.2004.10.073]
23. Wenham PR, Price WH, Blandell G. Apolipoprotein E genotyping by onestage PCR. Lancet 1991;337:1158-9. [1674030] [doi:10.1016/0140-6736(91)92823-K]
24. Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC Jr, Rimmler JB, Locke PA, Conneally PM, Schmader KE, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 1994;7:180-4. [7920638] [doi:10.1038/ng0694-180]
25. Scott WK, Saunders AM, Gaskell PC, Locke PA, Growdon JH, Farrer LA, Auerbach SA, Roses AD, Haines JL, Pericak-Vance MA. Apolipoprotein E ε2 does not increase risk of early-onset sporadic Alzheimer's Disease. Ann Neurol 1997;42:376-8. [9307262] [doi:10.1002/ana.410420317]
26. Pericak-Vance MA, Grubber J, Bailey LR, Hedges D, West S, Santoro L, Kemmerer B, Hall JL, Saunders AM, Roses AD, Small GW, Scott WK, Conneally PM, Vance JM, Haines JL. Identification of novel genes in late-onset Alzheimer's Disease. Exp Gerontol 2000;35:1343-52. [11113612] [doi:10.1016/S0531-5565(00)00196-0]
27. Holtzman DM, Bales KR, Tenkova T, Fagan AM, Parsadanian M, Sartorius LJ, Mackey B, Olney J, McKeel D, Wozniak D, Paul SM. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 2000;97:2892-7. [1069457] [doi:10.1073/pnas.050004797]
28. Berr C, Hauw JJ, Delaere P, Duyckaerts C, Amouyel P. Apolipoprotein E allele epsilon 4 is linked to increased deposition of the amyloid beta-peptide_A-beta in cases with or without Alzheimer's disease. Neurosci Lett 1994;178:221-4. [7824200] [doi:10.1016/0304-3940(94)90763-3]
29. Gomez-Isla T, West HL, Rebeck GW, Harr SD, Growdon JH, Locascio JJ, Perls TT, Lipsitz LA, Hyman BT. Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease. Ann Neurol 1996;39:62-70. [8572669] [doi:10.1002/ana.410390110]
30. Rose DA. Alzheimer Diseases: A model of gene mutations and susceptibility polymorphisms for complex psychiatric diseases. Am J Med Genet 1998;81:49-57. [9514588] [doi:10.1002/(SICI)1096-8628(19980207)81:1<49::AID-AJMG10>3.0.CO;2-W]
31. Perry RT, Collins JS, Harrell, Acton RT, Go RC. Investigation of association of polymorphisms in eight genes in southeastern African American Alzheimer disease patients as compared to age-matched controls. Am J Med Genet 2001;105:332-42. [11378846] [doi:10.1002/ajmg.1371]